SQA
NAVB

Simon Quick Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Simon Quick Advisors’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10
Closed – – 421
2022
Q1 		$0 Hold
10
– – ﹤0.01% 371
2021
Q4 		$0 Hold
10
– – ﹤0.01% 431
2021
Q3 		$0 Hold
10
– – ﹤0.01% 457
2021
Q2 		$0 Hold
10
– – ﹤0.01% 488
2021
Q1 		$0 Hold
10
– – ﹤0.01% 484
2020
Q4 		$0 Hold
10
– – ﹤0.01% 574
2020
Q3 		$0 Hold
10
– – ﹤0.01% 528
2020
Q2 		$0 Hold
10
– – ﹤0.01% 516
2020
Q1 		$1K Hold
10
– – ﹤0.01% 473
2019
Q4 		$0 Hold
10
– – ﹤0.01% 697
2019
Q3 		$0 Hold
10
– – ﹤0.01% 572
2019
Q2 		$6 Hold
10
– – ﹤0.01% 469
2019
Q1 		$0 Hold
10
– – ﹤0.01% 462
2018
Q4 		$0 Hold
10
– – ﹤0.01% 388
2018
Q3 		$0 Hold
10
– – ﹤0.01% 356
2018
Q2 		$0 Hold
10
– – ﹤0.01% 386
2018
Q1 		$0 Hold
10
– – ﹤0.01% 453
2017
Q4 		$0 Hold
10
– – ﹤0.01% 621
2017
Q3 		$0 Hold
10
– – ﹤0.01% 550
2017
Q2 		$0 Hold
10
– – ﹤0.01% 396
2017
Q1 		$0 Hold
10
– – ﹤0.01% 399
2016
Q4 		$1K Buy
+10
New +$159 ﹤0.01% 231

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simon Quick Advisors's NAVB Position: Q2 2022 in Review

Simon Quick Advisors sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2022, closing a stake of 10 shares.

Simon Quick Advisors first reported a position in NAVB in Q4 2016 and held it in 22 quarters. The position peaked at $1K in Q1 2020. 26 funds tracked by Wall St. Rank hold NAVB as of Q2 2022.

  • Simon Quick Advisors reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Simon Quick Advisors sold 10 Navidea Biopharmaceuticals Inc. shares in Q2 2022.
  • Simon Quick Advisors first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2016 and held it in 22 quarters.
  • Simon Quick Advisors's Navidea Biopharmaceuticals Inc. position peaked at $1K in Q1 2020.
  • 26 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2022.

Based on Simon Quick Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.